Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impairment of transendothelial leukocyte migration by iron complexes.
Sengoelge G, Kletzmayr J, Ferrara I, Perschl A, Hörl WH, Sunder-Plassmann G. Sengoelge G, et al. Among authors: perschl a. J Am Soc Nephrol. 2003 Oct;14(10):2639-44. doi: 10.1097/01.asn.0000087087.61306.4a. J Am Soc Nephrol. 2003. PMID: 14514743
A SAGE-based comparison between glomerular and aortic endothelial cells.
Sengoelge G, Luo W, Fine D, Perschl AM, Fierlbeck W, Haririan A, Sorensson J, Rehman TU, Hauser P, Trevick JS, Kulak SC, Wegner B, Ballermann BJ. Sengoelge G, et al. Among authors: perschl am. Am J Physiol Renal Physiol. 2005 Jun;288(6):F1290-300. doi: 10.1152/ajprenal.00076.2004. Epub 2005 Jan 18. Am J Physiol Renal Physiol. 2005. PMID: 15657302 Free article.
Assessing the impact of inland navigation on the faecal pollution status of large rivers: A novel integrated field approach.
Steinbacher SD, Ameen A, Demeter K, Lun D, Derx J, Lindner G, Sommer R, Linke RB, Kolm C, Zuser K, Heckel M, Perschl A, Blöschl G, Blaschke AP, Kirschner AKT, Farnleitner AH. Steinbacher SD, et al. Among authors: perschl a. Water Res. 2024 Sep 1;261:122029. doi: 10.1016/j.watres.2024.122029. Epub 2024 Jul 2. Water Res. 2024. PMID: 38996728 Free article.
Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours.
Eskens FA, Dumez H, Hoekstra R, Perschl A, Brindley C, Böttcher S, Wynendaele W, Drevs J, Verweij J, van Oosterom AT. Eskens FA, et al. Among authors: perschl a. Eur J Cancer. 2003 May;39(7):917-26. doi: 10.1016/s0959-8049(03)00057-1. Eur J Cancer. 2003. PMID: 12706360 Clinical Trial.
20 results